Reversible 'Unstable' Abdominal Angina Caused by Ruptured Plaque of the Superior Mesenteric Artery: Clinical and Radiological Correlations.

Autor: Yaari S; Department of Medicine, Hadassah Hebrew University Hospital, Mount Scopus, Jerusalem, Israel., Hiller N; Department of Radiology, Hadassah Hebrew University Hospital, Mount Scopus, Jerusalem, Israel., Samet Y; Department of Vascular Surgery, Shaare Zedek Medical Center, Jerusalem, Israel., Heyman SN; Department of Medicine, Hadassah Hebrew University Hospital, Mount Scopus, Jerusalem, Israel.
Jazyk: angličtina
Zdroj: European journal of case reports in internal medicine [Eur J Case Rep Intern Med] 2023 Mar 30; Vol. 10 (4), pp. 003766. Date of Electronic Publication: 2023 Mar 30 (Print Publication: 2023).
DOI: 10.12890/2023_003766
Abstrakt: Unstable angina, characteristic of coronary artery disease, is caused by in-situ clot formation complicating ruptured atheromatous plaque. Abdominal angina, however, usually reflects chronic mesenteric ischaemia, caused by multi-vessel stable plaques involving mesenteric arteries. Herein, we describe a patient with new-onset abdominal pain caused by a ruptured atheromatous plaque at the superior mesenteric root. The diagnosis was based on an evident reversible epigastric bruit and high-degree eccentric stenosis caused by a non-calcified atheroma. Symptoms and bruit resolved within 3 weeks on aspirin and statins with regression of the stenotic lesion. Although the condition is likely common, this is the first clear-cut report compatible with 'unstable' abdominal angina, resolved by conservative treatment.
Learning Points: Resembling unstable angina pectoris, ruptured atheromatous plaque in mesenteric vessels can develop, clinically manifested by new-onset abdominal angina.This condition may be reversible under treatment with antiplatelet medications and statins.Searching for abdominal bruit is invaluable in the assessment of unexplained abdominal pain.
Competing Interests: Conflicts of Interests: The Authors declare that there are no competing interests.
(© EFIM 2023.)
Databáze: MEDLINE